Posted inGenetics StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod April 6, 2026 Eli Lilly (NYSE: LLY) won the approval it sought when the FDA authorized the company’s oral obesity drug Foundayo™ (orforglipron),…
Posted inBiotechnology Japanese Health Promotion Questionnaire: Validity Confirmed April 6, 2026 In recent advances within the field of public health education, a newly published study offers significant insights into the validity…
Posted inMedical Technology Zeto’s latest EEG device garners FDA 510(k) clearance for outpatient use April 5, 2026 Zeto, which makes brainwave monitors for emergency rooms, received a third FDA clearance for an EEG device. The latest is…
Posted inBiotechnology Frailty, Depression, Social Participation Linked in Older Adults April 5, 2026 In an era where aging populations are growing exponentially, understanding the intricate dynamics of frailty in older adults is more…
Posted inMedical Technology US, UK regulators bolster medical device collaboration while lifting tariffs April 5, 2026 The U.S. FDA and the U.K.’s Medicines and Healthcare products Regulatory Agency have agreed to bolster their ongoing medical technology…
Posted inBiotechnology Seismic Impact on Integrated Slope Stabilization: Numerical Study April 5, 2026 In a groundbreaking advancement at the intersection of civil engineering and seismology, new research spearheaded by Y. Wang offers profound…
Posted inBiotechnology Clinical Outcomes and Risks in Post-Ibrutinib Transplant April 5, 2026 In an era marked by rapid advancements in targeted therapies for hematologic malignancies, the management of relapsed or refractory mantle…
Posted inBiotechnology Whole-Body MRI Predicts Ovarian Cancer Treatment Outcomes April 5, 2026 In a groundbreaking advancement poised to reshape the clinical management of advanced ovarian cancer, a team of researchers has unveiled…
Posted inBiotechnology Distributed Fusion Framework Predicts Breast Cancer Recurrence April 5, 2026 In a groundbreaking leap towards revolutionizing cancer prognosis, a team of researchers has unveiled a new distributed fusion framework tailored…
Posted inBiotechnology Inside TCF3::HLF-Positive B-ALL: Clinical and Molecular Insights April 4, 2026 In the realm of hematologic malignancies, few subtypes have proved as enigmatic and challenging as TCF3::HLF-positive B-cell acute lymphoblastic leukemia…